Oasmia Pharma (OASM) Enters New Shares Private Placement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Dow, S&P inch up as AmEx gains; Netflix slump drags down Nasdaq
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Stocks off two-month low as fear of Middle East escalation eases
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- Netflix, Tesla, Amex, P&G fall premarket; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Oasmia Pharmaceutical intends to convene an extraordinary general meeting
October 24, 2016 7:11 AM EDTUppsala, Sweden, Oct. 24, 2016 (GLOBE NEWSWIRE) -- Preliminary agenda
1.   Election of chairman of the meeting
2.   Preparation and approval of the voting list
3.   Approval of the agenda
4.   Election of one or two persons to verify the minutes in addition to the chairman
5.   Determination as to whether the meeting has been properly convened
6.   Determination of the number of directors
7.   Election of board members and chairman of the board of directors
... More
Oasmia enters into collaboration agreement for novel cancer project
October 24, 2016 7:08 AM EDTUppsala, Sweden, Oct. 24, 2016 (GLOBE NEWSWIRE) -- Oasmia acquires the project and strengthens its oncology project portfolio. Karo Pharma receives 3,080,000 newly issued shares as a down payment corresponding to a value of MSEK 25. Additionally, Oasmia will pay Karo Pharma 20% of all future revenues generated by the project for Oasmia. Â Â
Oasmia will continue the development process and will be responsible for all project expenses.Â
"This is a solid industrial solution where the companies can focus within their respective areas. Oasmia, which has several cancer projects in both early and late developmental phase, strengthens its already... More
Oasmia announces private placement of new shares
October 22, 2016 8:46 AM EDTUppsala, Sweden, Oct. 22, 2016 (GLOBE NEWSWIRE) -- The price of the New Shares will be determined through an accelerated book building procedure. The book building will begin on October 22, 2016.Â
The Company intends to use the proceeds from the Private Placement to strengthen the working capital as well as finance the continued operations and further development of additional human and veterinary products based on the XR17 technology.Â
The Private Placement is subject to, inter alia, a resolution by the Board of Directors of Oasmia, pursuant to the authorization granted by the... More
